Proof of Concept of Diagnostic Aid Technology for Depression Using Blood TestsTogether with Kyushu University and HMT, Bringing the Testing Model to Society Read more
Three Labs in Japan and Spain to Receive Novel Compact Ascend Evo 1.0 GHz Magnets UTRECHT, The Netherlands–(BUSINESS WIRE)– At the Euromar 2022 Conference, Bruker announced three new customer orders for GHz systems, which will incorporate novel, compact 1.0 GHzNMR magnets for structural biology applications and clinical research in single-story laboratories. The new Ascend Evo... Read more
ETTLINGEN, Germany–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today has launched PhenoRiskPACS™ RuO, a research-use-only NMR test for molecular phenomics research on ‘Long COVID’ patients’ blood samples, using a multiplexed combination of biomarkers discovered at the Australian National Phenome Center (ANPC) at Murdoch University, under Director Jeremy Nicholson. The PhenoRiskPACS™ RuO test is promising for research... Read more
Collaborations demonstrate role as a core partner in multidisciplinary cancer care Chicago, US – June 3, 2022: From early detection to remote monitoring and data sharing, GE Healthcare’s innovative suite of diagnostic and treatment technologies are designed to help improve detection, clinical efficiency, operational efficiency, and outcomes for cancer patients. “GE Healthcare is collaborating with health... Read more